Good to see this management team has the willing to reset market values, but how? I only found highlighted risk factors... Anyway something good to be expected in the near future. A peer reviewed paper, shouldn't take long for summarizing a P1 trial? IND and the fast track, hopefully they can work more efficiently? Further funding by Life Biosciences? Not favorable but no better choices now.
Ann: Appendix 4E & Annual Report 2019, page-2
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 22150822 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130766828 | 31 |
View Market Depth
| Last trade - 12.49pm 09/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable